Antimicrobial susceptibility testing of Chlamydia trachomatis using a reverse transcriptase PCR-based method

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 9, 1999, Pages 2311-2313

  Cross, N A ^a   Kellock, D J ^b   Kinghorn, G R ^b   Taraktchoglou, M ^a   Bataki, E ^a   Oxley, K M ^a   Hawkey, P M ^c   Eley, A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; ERYTHROMYCIN; MOXIFLOXACIN; OFLOXACIN; RNA DIRECTED DNA POLYMERASE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; IMMUNOFLUORESCENCE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRAIN DIFFERENCE;

EID: 0032850550     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.9.2311     Document Type: Article

References (23)

1. Alexander, E. R., and H. R. Harrison. 1983. Role of Chlamydia trachomatis in perinatal infection. Rev. Infect. Dis. 5:713-719.
2. Barbour, A. G., K. Aman, T. Hackstadt, L. Perry, and H. D. Caldwell. 1982. Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J. Bacteriol. 151:420-428.
3. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1994. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 2:94-98.
4. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1995. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect. Immun. 63: 199-205.
5. Bell, T. A., I. K. Sandstrom, D. A. Eschenbach, D. Hummel, C.-C. Kuo, S.-P. Wang, J. T. Grayston, H. M. Foy, W. E. Stamm, and K. K. Holmes. 1982. Treatment of Chlamydia trachomatis in pregnancy with amoxycillin, p. 221-224. In P.-A. Mardh, K. K. Holmes, J. D. Oriel, P. Piot, and J. Schachter (ed.), Chlamydial infections. Elsevier, Amsterdam, The Netherlands.
6. Brunham, R. C., I. W. MacLean, B. Binns, and R. W. Peeling. 1985. Chlamydia trachomatis: its role in tubal infertility. J. Infect. Dis. 152:1275-1282.
7. Cates, W., R. T. Rolfs, and S. O. Aral. 1990. Sexually transmitted diseases, pelvic inflammatory disease, and infertility: an epidemiologic update. Epidemiol. Rev. 12:199-219.
8. Csango, P. A., T. Gundersen, and I. M. Martinsen. 1985. Effect of amoxycillin on simultaneous Chlamydia trachomatis infection in men with gonococcal urethritis: comparison with three dosage regimens. Sex. Trans. Dis. 12:93-96.
9. Grayston, J. T., and S. Wang. 1975. New knowledge of chlamydiae and the disease they cause. J. Infect. Dis. 132:87-106.
10. Holland, S. M., A. P. Hudson, L. Bobo, J. A. Whittum-Hudson, R. P. Viscidi, T. C. Quinn, and H. R. Taylor. 1992. Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect. Immun. 60:2040-2047.
11. How, S. J., D. Hobson, C. A. Hart, and E. Quayle. 1985. A comparison of the in vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain. J. Antimicrob. Chemother. 15:399-404.
12. Jones, B. R., B. Van der Pol, and R. B. Johnson. 1997. Susceptibility of Chlamydia trachomatis to trovafloxacin. J. Antimicrob. Chemother. 39 (Suppl. B):63-65.
13. Khan, M. A., C. W. Potter, and R. M. Sharrard. 1996. A reverse transcriptase-PCR based assay for in vitro antibiotic susceptibility testing of Chlamydia pneumoniae. J. Antimicrob. Chemother. 37:677-685.
14. Lan, J., I. Melgers, C. J. L. M. Meijer, J. M. M. Walboomers, R. Roorendaal, C. Burger, O. P. Bleker, and A. J. C. V.-D. Brule. 1995. Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR. J. Clin. Microbiol. 33:3194-3197.
15. Matsumoto, A., and G. P. Manire. 1970. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 101:278-285.
16. Moulder, J. W. 1991. Interaction of chlamydiae and the host cells in vitro. Microbiol. Rev. 55:143-190.
17. Moulder, J. W. 1993. Why is Chlamydia susceptible to penicillin in the absence of peptidoglycan? Infect. Agents Dis. 2:87-99.
18. Peeling, R. W., W. R. Bowle, J. R. Dillon, R. Johnson, R. B. Jones, B. Van der Pol, D. T. Low, D. H. Martin, J. Newhall, J. Orfila, R. Rice, J. Schachter, and J. Moncada. 1994. Standardization of antimicrobial susceptibility testing for Chlamydia trachomatis, p. 346-349. In J. Orfila, G. I. Byrne, M. A. Chernesky, J. T. Grayston, R. B. Jones, G. L. Ridgway, P. Saikku, J. Schachter, W. E. Stamm, and R. S. Stephens (ed.), Chlamydial infections. Proceedings of the Eighth International Symposium on Human Chlamydial Infections. Societa Editrice Esculapio, Chantilly, France.
19. Rice, R. J., V. Bhullar, S. H. Mitchell, J. Bullard, and J. S. Knapp. 1995. Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease. Antimicrob. Agents Chemother. 39:760-762.
20. Simms, I., M. Catchpole, R. Brugha, P. Rogers, H. Mallinson, and A. Nicoll. 1997. Epidemiology of genital Chlamydia trachomatis in England and Wales. Genitourin. Med. 73:122-126.
21. Tanami, Y., and Y. Yamada. 1973. Miniature cell formation in Chlamydia psittaci. J. Bacteriol. 114:408-412.
22. Webberley, J. M., R. S. Matthews, J. M. Andrews, and R. Wise. 1987. Commercially available fluorescein-conjugated monoclonal antibody for determining the in vitro activity of antimicrobial agents against Chlamydia trachomatis. Eur. J. Clin. Microbiol. 6:587-589.
23. Woodcock, J. M., J. M. Andrews, R. J. Boswell, N. N. Brenwald, and R. Wise. 1997. In vitro activity of BAY 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother. 41:101-106.